[EN] MITOCHONDRIA-TARGETED ATOVAQUONE: A MORE POTENT AND MORE EFFECTIVE ANTITUMOR, ANTIMICROBIAL, AND ANTIMALARIAL DRUG<br/>[FR] ATOVAQUONE CIBLÉE SUR LES MITOCHONDRIES : MÉDICAMENT ANTITUMORAL, ANTIMICROBIEN ET ANTIPALUDIQUE PLUS PUISSANT ET PLUS EFFICACE
申请人:MEDICAL COLLEGE WISCONSIN INC
公开号:WO2021081500A1
公开(公告)日:2021-04-29
The present invention provides novel mitochondria-targeted Atovaquone compounds (Mito-ATO), a mitochondria-targeted derivative of Atovaquone, and methods of using such compounds. Methods of treating cancer using mito-ATO are also provided. Methods of enhancing an anti-tumor immune response by administering mito-ATO are further provided.
本发明提供了新型线粒体靶向阿托伐醌化合物(Mito-ATO),即阿托伐醌的线粒体靶向衍生物,以及使用这些化合物的方法。还提供了使用Mito-ATO治疗癌症的方法。此外,还提供了通过给予Mito-ATO来增强抗肿瘤免疫反应的方法。